Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic
- PMID: 33971892
- PMCID: PMC8107802
- DOI: 10.1186/s12954-021-00499-z
Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic
Abstract
Background and aims: People who inject drugs may be particularly vulnerable to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to underlying health problems, stigma and social vulnerabilities. Harm reduction services, including needle exchange programs (NEP), have been subjected to varying degrees of disruption in the world, especially in the beginning of the coronavirus disease 2019 (COVID-19) pandemic. Compared to responses in other countries, Sweden's initial strategy toward limiting the spread and impact of COVID-19 was less restrictive to its citizens with no imposed general societal lockdown. In this study, we investigate changes in drug use patterns, utilization of NEP associated health services, COVID-19 health literacy and the prevalence of SARS-CoV-2 antibodies among NEP clients in Stockholm during the COVID-19 pandemic.
Methods: NEP visits and services provided (needles/syringes, HIV and hepatitis C tests and treatment, naloxone distributed) and overall mortality among NEP clients between January 1 and October 31, 2020, were used for trend analyses in comparison with corresponding 2019 data. Between July 27 and October 2, 2020, NEP clients (n = 232) responded to a 27 item COVID-19 Health Literacy Questionnaire. SARS CoV-2 IgG antibody tests (n = 779) were performed between June 15 and October 31, 2020.
Results: During the COVID-19 pandemic number of clients, client visits, naloxone distribution and HCV tests remained stable compared to 2019, while distribution of needles/syringes increased (p < 0.0001); number of HIV tests and HCV treatments decreased (p < 0.05); and mortality decreased (< 0.01). Overall, the level of health literacy concerning transmission routes and protective measures was high. SARS-CoV-2 antibody prevalence was 5.4% (95% CI 4.0-7.2).
Conclusions: The Stockholm NEP managed to maintain a high level of clients and services during the pandemic. In general, COVID-19 health literacy was adequate and the overall SARS-CoV-2 antibody prevalence was low compared to the general population, which highlights a need for prioritized and targeted COVID-19 vaccination among PWID.
Keywords: COVID-19; Harm reduction; Health literacy; Needle exchange program; People who inject drugs; SARS-CoV-2.
Conflict of interest statement
KL, CW, EH and AH have no conflict of interest. MK has received honoraria for lectures/consultancy from AbbVie, Gilead, MSD, Mundipharma, DnE Pharma and Nordic Drugs, and has received research grants from Gilead and Nordic Drugs.
Figures


Similar articles
-
Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.Public Health. 2021 Mar;192:8-11. doi: 10.1016/j.puhe.2021.01.004. Epub 2021 Jan 15. Public Health. 2021. PMID: 33601307 Free PMC article.
-
Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in metropolitan Chicago.PLoS One. 2025 Jan 7;20(1):e0293238. doi: 10.1371/journal.pone.0293238. eCollection 2025. PLoS One. 2025. PMID: 39774394 Free PMC article.
-
The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.Public Health. 2023 Nov;224:90-97. doi: 10.1016/j.puhe.2023.08.019. Epub 2023 Sep 22. Public Health. 2023. PMID: 37742585
-
COVID-19 on the Nile: Review on the Management and Outcomes of the COVID-19 Pandemic in the Arab Republic of Egypt from February to August 2020.Int J Environ Res Public Health. 2021 Feb 8;18(4):1588. doi: 10.3390/ijerph18041588. Int J Environ Res Public Health. 2021. PMID: 33567519 Free PMC article. Review.
-
Stigma and Discrimination (SAD) at the Time of the SARS-CoV-2 Pandemic.Int J Environ Res Public Health. 2020 Aug 31;17(17):6341. doi: 10.3390/ijerph17176341. Int J Environ Res Public Health. 2020. PMID: 32878180 Free PMC article. Review.
Cited by
-
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya.Harm Reduct J. 2023 Feb 23;20(1):21. doi: 10.1186/s12954-023-00754-5. Harm Reduct J. 2023. PMID: 36823596 Free PMC article.
-
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA.Harm Reduct J. 2023 Jan 7;20(1):1. doi: 10.1186/s12954-023-00732-x. Harm Reduct J. 2023. PMID: 36611167 Free PMC article.
-
Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study.Harm Reduct J. 2022 Dec 12;19(1):140. doi: 10.1186/s12954-022-00713-6. Harm Reduct J. 2022. PMID: 36503439 Free PMC article.
-
The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia.BMJ Open. 2023 Jul 3;13(7):e071665. doi: 10.1136/bmjopen-2023-071665. BMJ Open. 2023. PMID: 37400235 Free PMC article.
-
Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis.Addiction. 2023 Sep;118(9):1763-1774. doi: 10.1111/add.16203. Epub 2023 May 1. Addiction. 2023. PMID: 37039246 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous